MR imaging findings of elastofibroma dorsi in correlation with pathological features: our experience

Faccioli, Niccolò; Foti, Giovanni; Comai, Alessio; Cugini, Christian; Guarise, Alessandro; Mucelli, Roberto Pozzi

doi:10.1007/s11547-009-0442-2

Cited by 20 publications

(16 citation statements)

References 14 publications

(72 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some may argue that, with advances in cross-sectional imaging, the typical appearance of elastofibroma on MRI or CT is sufficient to confirm the diagnosis and precludes the need for biopsy. [15][16][17] At our institution, it is standard practice to obtain a histological diagnosis in patients presenting with a probable elastofibroma, unless a clinically detectable contralateral lesion is present. A percutaneous biopsy may be performed with minimal discomfort under local anaesthetic at the time of the initial consultation.…”

Section: Discussionmentioning

confidence: 99%

Elastofibroma dorsi: The clunking tumour that need not cause alarm

Smith

Hannay

Thway

et al. 2016

annals

View full text Add to dashboard Cite

Introduction Elastofibromas are rare, pseudo-tumours arising at the inferior pole of the scapula that have a characteristic presentation. Due to their tissue of origin and size, they may often be mistaken for soft tissue sarcomas. We present the management of patients diagnosed with elastofibroma at a single institution. Methods Patients diagnosed with elastofibroma between January 1995 and January 2015 were identified from a prospectively maintained histopathology database. Electronic patient records, imaging and pathology reports were retrieved and reviewed. Results Thirty seven patients were identified, with a median age of 66 years and a male-to-female ratio of 1:1.6. All tumours occurred in the characteristic subscapular location. The median maximum tumour diameter was 8.2cm. A synchronous contralateral lesion (15.8%) was found in six patients. Cross-sectional imaging was performed in 29 patients, with magnetic resonance imaging the most common modality (59.5%). Diagnosis was confirmed with percutaneous biopsy in all but one patient, who proceeded directly to surgery. Eighteen patients were managed non-operatively; 19 opted for surgical excision due to significant symptoms. Excision was performed in a marginal fashion and, at a median follow-up of 5 months, no functional impairment or local recurrences were observed. Conclusions Soft tissue masses greater than 5cm in diameter should prompt the clinician to exclude soft tissue sarcoma. The diagnosis of elastofibroma may be alluded to by its typical presentation and can be confirmed by percutaneous biopsy. After excluding malignancy, these lesions can be safely managed non-operatively, with surgery reserved for symptomatic patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Elastofibroma dorsi: The clunking tumour that need not cause alarm

Smith

Hannay

Thway

et al. 2016

annals

View full text Add to dashboard Cite

show abstract

“…As the 18 F-FDG PET scan has becomes more popular for cancer screening, more asymptomatic cases of ED may be identified by radiologists. To avoid unnecessary further examination or biopsy, radiologists and physicians should be aware of the characteristic findings of ED (14,15). Several authors recommend resection for symptomatic cases only (5,7,11,15).…”

Section: Discussionmentioning

confidence: 99%

Elastofibroma dorsi: Surgical indications and complications of a rare soft tissue tumor

Nagano

Yokouchi

Setoyama

et al. 2014

Molecular and Clinical Oncology

View full text Add to dashboard Cite

Abstract. Elastofibroma dorsi (ED) is a tumor that develops in the space between the lower angle of the scapula and the posterior thoracic wall. Due to the rarity of this type of tumor, the number of reported consecutive series is limited. Surgical excision, usually recommended for symptomatic cases to confirm diagnosis and relieve symptoms, has been associated with a high complication rate. To analyze the clinical characteristics and outcomes of surgical treatment, we retrospectively reviewed 20 consecutive cases of surgically resected ED. Of the 20 patients, 14 (70%) exhibited preoperative symptoms associated with the tumor. The mean diameter of the resected tumors averaged 72 mm (range, 45-110 mm). The surgical outcomes were satisfactory, except for the development of hematoma or seroma in 9 cases (43%), 8 of which achieved a complete resolution with conservative treatment. Age, hypertension, the presence of preoperative tumor-related symptoms and intraoperative bleeding were not found to be significantly associated with the incidence of hematoma. However, tumor diameter and the duration of postoperative drainage were significantly associated with occurrence of hematoma (P= 0.02 and P= 0.01, respectively). Surgical resection should only be recommended for symptomatic patients, due to the high incidence of postoperative complications. To prevent the development of postoperative hematoma or seroma, careful observation of the wound, with suction drainage for >7 days and additional surgical procedures to facilitate adhesion of the wound margins, are recommended.

show abstract

“…The hypoechoic tissue strands represent fat, and the hyperechoic tissue strands represent fibroelastic tissue. No significant flow is found on color Doppler imaging . Further investigation on CT or MRI is usually needed to delineate the full extent of the lesion, owing to its obscuration by the scapula (Figure B).…”

Section: Chest‐wall Pathologymentioning

confidence: 99%

“…No significant flow is found on color Doppler imaging. [28][29][30][31][32][33] Further investigation on CT or MRI is usually needed to delineate the full extent of the lesion, owing to its obscuration by the scapula (Figure 22B).…”

Section: Tumormentioning

confidence: 99%